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THE EFFICACY OF ALTERNATIVE TREATMENTS IN MAINTAINING METABOLIC CONTROL OF 
GLYCOGEN STORAGE DISEASE (GSD) TYPE I: A SYSTEMATIC REVIEW. A.M.R. Hayes, Henrietta 
Schmoll School of Health, Department of Nutrition and Exercise Sciences, St. Catherine University, St. 
Paul, MN. 
         
Glycogen storage disease (GSD) is a rare genetic disorder that disrupts proper metabolic function with 
consequences of hypoglycemia, hyperlactatemia, hyperuricemia, and hyperlipidemia that ultimately 
compromises health. Maintaining stable blood glucose levels through starch therapy is the current 
standard treatment. However, such onerous therapy requires frequent feedings and interrupts the normal 
sleep cycle of patients and their families. The purpose of this systematic review was to evaluate the 
efficacy of alternative treatments in comparison to the standard starch therapy for maintaining metabolic 
control in patients diagnosed with GSD Type I. A MEDLINE and EBSCO search was conducted using 
search terms “glycogen storage disease” and “treatment.” Studies were limited to those that addressed 
GSD Type I, were written in English, and were published between 1990 and 2014. Of the six studies 
reviewed, two evaluated the effectiveness of a modified experimental starch, one evaluated the use of a 
medium-chain triglyceride supplement, one evaluated dextrose and a combination of dextrose and 
cornstarch, and two evaluated aggressive cornstarch therapies. Changes in levels of blood glucose and 
lactate levels were reported or described in all studies as indicators of metabolic control. Overall, this 
research indicates the importance of maintaining metabolic control in the treatment of GSD Type I 
through stable blood glucose levels and lowered lactate levels. Due to the diverse needs of each patient, 
standard treatments are difficult to establish. Future research is needed to evaluate the effectiveness of 
novel treatments for GSD among a wider subject population for sustained time periods.    
 
